Discontinued — last reported Q4 '25
Investing
Business Sale Proceeds
Year-over-year, this metric declined by 100.0%, from $11.28M to $0.00.
Analysis
StatementCash Flow Statement
SectionInvesting
CategoryCapital Allocation
SignalContext dependent
VolatilityVolatile
First reportedQ1 2013
Last reportedQ4 2025Feb 19, 2026
How to read this metric
An increase signals portfolio optimization or a strategic pivot, while a lack of proceeds suggests a stable, long-term asset base.
Detailed definition
This metric represents the cash inflows received from the divestiture or sale of business segments, product lines, or su...
Peer comparison
Occurs sporadically; peers often divest legacy segments to focus on high-margin innovation areas like continuous glucose monitoring or diagnostics.
Metric ID:
proceeds_from_sale_of_businessHistorical Data
13 periods
| Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $12.35M | $12.35M | $12.35M | $12.35M | $110.30M | $8.30M | $11.28M | $11.28M | $11.28M | $11.28M | $0.00 | $0.00 |
| QoQ Change | — | — | +0.0% | +0.0% | +0.0% | +793.1% | -92.5% | +35.8% | +0.0% | +0.0% | +0.0% | -100.0% | — |
| YoY Change | — | — | — | — | — | +793.1% | -32.8% | — | — | -89.8% | +35.8% | -100.0% | -100.0% |
Range$0.00 – $110.30M
Avg YoY Growth+84.4%
Median YoY Growth-61.3%
Current Streak2 quarters decline
Business Sale Proceeds at Other Companies
Frequently Asked Questions
- What is IDEX's business sale proceeds?
- IDEX (IEX) reported business sale proceeds of $0.00 in Q4 2025.
- How has IDEX's business sale proceeds changed year-over-year?
- IDEX's business sale proceeds decreased by 100.0% year-over-year, from $11.28M to $0.00.
- What does business sale proceeds mean?
- Cash received from selling off parts of the business.